Request Demo
Last update 16 May 2025
Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Private Company | Subsidiary Company|2021|Jiangsu Sheng, China
Private Company | Subsidiary Company|2021|Jiangsu Sheng, China
Last update 16 May 2025
Overview
Basic Info
Introduction Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd. was established on November 19, 2021, with its business scope including licensed activities such as pharmaceutical import and export, drug wholesale, and general activities like technical services, development, consulting, exchange, transfer, and promotion. |
Tags
Endocrinology and Metabolic Disease
Synthetic peptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20251037
一项在经单纯饮食运动干预体重控制不佳的中国非糖尿病的中、重度肥胖受试者中评估BGM0504注射液和替尔泊肽注射液用于体重控制的初步疗效和安全性的多中心、随机、开放标签的探索性Ⅱ期临床研究
[Translation] A multicenter, randomized, open-label, exploratory Phase II clinical study to evaluate the preliminary efficacy and safety of BGM0504 injection and telpotide injection for weight control in Chinese non-diabetic moderate to severe obese subjects whose weight is not well controlled by diet and exercise intervention alone
CTR20250891
在超重或肥胖志愿者中评价BGM0504注射液的胃排空延迟效应及与盐酸二甲双胍、华法林钠片的药物相互作用
[Translation] Evaluation of the delayed gastric emptying effect of BGM0504 injection and its drug interactions with metformin hydrochloride and warfarin sodium tablets in overweight or obese volunteers
CTR20243983
一项在中国非糖尿病的超重或肥胖受试者中评价 BGM0504 注射液用于体重控制的有效性和安全性的Ⅲ期多中心、随机、双盲、安慰剂平行对照的临床研究
[Translation] A Phase III multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of BGM0504 injection for weight management in Chinese non-diabetic overweight or obese subjects
100 Clinical Results associated with Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Login to view more data
100 Translational Medicine associated with Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 25 Jun 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free